News
Influenza vaccine may offer much more than flu prevention
“There are some pieces of evidence that suggest influenza vaccination may release anti-inflammatory mediators that can stabilize the atheroma...
News
Pivotal trials in blood cancers don’t mirror patient populations
“The results from this study should lead to questions about the generalizability of drug safety and efficacy in populations we serve as medical...
News
Vitamin D deficiency clearly linked to inflammation
“Improving vitamin D status may reduce chronic inflammation, but only for people with vitamin D deficiency.”
News
Where women’s voices still get heard less
Only about one-third of board review lectures are presented by women oncologists, and early-career disparities also persist.
News
Ultrasound-guided nerve blocks improve fracture pain
Because hip fractures commonly affect older populations and those who are frail, treatment of the substantial pain that can occur perioperatively...
News
Strength training overcomes bone effects of vegan diet
Bone microarchitecture differences observed between vegans and omnivores disappear when both practice progressive resistance training.
News
Hyperthyroidism rebound in pregnancy boosts adverse outcomes
“A low dose of antithyroid medications may be a good choice for women with subnormal TSH and/or positive TRAb in early pregnancy.”
News
Fewer transplants for MM with quadruplet therapy?
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Article
No more injections after one-off gene therapy in hemophilia B
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
News
‘Superior’ CLL regimen cuts chemo in half
Where chemo is still used to treat CLL, this three-cycle regimen combined with ibrutinib and obinutuzumab shows progression-free and overall...
News
Debated: Nonfactor versus gene therapy for hemophilia
Hemophilia A patients have the option of enrolling in clinical trials for gene therapy, but many are satisfied with the efficacy of subcutaneous...
News
Venetoclax combos prolong progression-free CLL survival
Time-limited targeted therapy with venetoclax plus obinutuzumab outperforms chemoimmunotherapy for CLL progression-free survival.
News
Severe COVID-19 and blood cancer: Plasma therapy may help
Some data indicate that certain patients who cannot mount a strong immune response to SARS-CoV-2 infection may benefit.
News
Inebilizumab beneficial across genotypes in NMOSD
"These data illustrate how mechanistic precision in treatment design can help patients gain benefit from their regimen regardless of the genetic...